On May 5, 2025, TuHURA Biosciences, Inc. amended a merger agreement with Kineta, outlining financial considerations and conditions related to the merger; additionally, the former Chief Scientific Officer's employment was terminated effective December 16, 2024, with a severance payment of $145,833.34 and vesting of stock options confirmed.